Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTUITIVE SURGICAL INCISRG · Entity 2878 | EVP & Chief Strategy & Corp Op | April 25, 2025 | April 29, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTUITIVE SURGICAL INC
Report date April 25, 2025 · Filed April 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,224 |
Ending reported balance
After 2025-04-29 transaction · row 12
12 source rows · reconciled sequenceRow 1 · 2025-04-25 · Exercise / conversion · Acquired 188 · Balance 5,412 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 2 · 2025-04-25 · Sale · Disposed 188 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 3 · 2025-04-25 · Exercise / conversion · Acquired 119 · Balance 5,343 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 4 · 2025-04-25 · Sale · Disposed 119 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 5 · 2025-04-25 · Exercise / conversion · Acquired 119 · Balance 5,343 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 6 · 2025-04-25 · Sale · Disposed 119 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 7 · 2025-04-25 · Exercise / conversion · Acquired 188 · Balance 5,412 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 8 · 2025-04-25 · Sale · Disposed 188 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 9 · 2025-04-28 · Exercise / conversion · Acquired 188 · Balance 5,412 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 10 · 2025-04-28 · Sale · Disposed 188 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 11 · 2025-04-29 · Exercise / conversion · Acquired 188 · Balance 5,412 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. Row 12 · 2025-04-29 · Sale · Disposed 188 · Balance 5,224 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $208.90 · Expires 2029-08-28 | Direct | 2,068 |
Reported balance
After 2025-04-25 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2025-04-25 · Exercise / conversion · Disposed 188 · Balance 2,068 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F2: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $208.90 · Expires 2029-08-28 | Direct | 1,880 |
Reported balance
After 2025-04-29 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2025-04-29 · Exercise / conversion · Disposed 188 · Balance 1,880 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F2: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $229.39 · Expires 2030-02-27 | Direct | 2,634 |
Reported balance
After 2025-04-25 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2025-04-25 · Exercise / conversion · Disposed 119 · Balance 2,634 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F3: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $290.33 · Expires 2029-02-28 | Direct | 2,068 |
Reported balance
After 2025-04-25 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2025-04-25 · Exercise / conversion · Disposed 188 · Balance 2,068 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $290.33 · Expires 2029-02-28 | Direct | 1,880 |
Reported balance
After 2025-04-28 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2025-04-28 · Exercise / conversion · Disposed 188 · Balance 1,880 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $304.67 · Expires 2030-08-09 | Direct | 2,634 |
Reported balance
After 2025-04-25 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2025-04-25 · Exercise / conversion · Disposed 119 · Balance 2,634 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025. F5: 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 12, 2025.
F2: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F3: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F5: 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2022 Filed Apr 28, 2022 00:45 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 795 | $245.60 | $195,252.00 |
DisclosureSEC source: 0001567619-22-009055 · doc1.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 19:48 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 2,175 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-22-000040 · edgardoc.xml · derivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,347 Underlying: Common Stock · 2,175 shares Expires 2024-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. F2 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 19:48 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Tax withholdingCommon Stock | 1,008 | $290.33 | $292,652.64 |
DisclosureSEC source: 0001035267-22-000040 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,355 Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 19:48 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 2,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-22-000040 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 19:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 6,015 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-22-000056 · edgardoc.xml · derivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,015 Underlying: Common Stock · 6,015 shares Expires 2026-02-28 F2 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 19:47 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 9,023 | $0.00 Strike: $290.33 | $0.00 |
DisclosureSEC source: 0001035267-22-000056 · edgardoc.xml · derivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,023 Underlying: Common Stock · 9,023 shares Expires 2029-02-28 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 19:48 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 1,590 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-22-000040 · edgardoc.xml · derivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,764 Underlying: Common Stock · 1,590 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. F2 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 19:48 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Tax withholdingCommon Stock | 737 | $293.51 | $216,316.87 |
DisclosureSEC source: 0001035267-22-000040 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,188 F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 19:48 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 1,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-22-000040 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 02:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 2,124 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-22-000024 · edgardoc.xml · derivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,124 Underlying: Common Stock · 2,124 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 02:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 2,874 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-22-000024 · edgardoc.xml · derivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,874 shares Expires 2022-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 02:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Tax withholdingCommon Stock | 928 | $289.31 | $268,479.68 |
DisclosureSEC source: 0001035267-22-000024 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,335 F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 02:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 2,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-22-000024 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 02:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Tax withholdingCommon Stock | 903 | $289.31 | $261,246.93 |
DisclosureSEC source: 0001035267-22-000024 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,139 F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 02:30 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 2,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-22-000024 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 597 | $0.00 Strike: $245.60 | $0.00 |
DisclosureSEC source: 0001035267-22-000008 · edgardoc.xml · derivative · entry 12 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,272 Underlying: Common Stock · 597 shares Expires 2031-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 273 | $0.00 Strike: $242.34 | $0.00 |
DisclosureSEC source: 0001035267-22-000008 · edgardoc.xml · derivative · entry 11 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,352 Underlying: Common Stock · 273 shares Expires 2030-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 270 | $0.00 Strike: $179.70 | $0.00 |
DisclosureSEC source: 0001035267-22-000008 · edgardoc.xml · derivative · entry 10 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,808 Underlying: Common Stock · 270 shares Expires 2030-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 270 | $0.00 Strike: $177.99 | $0.00 |
DisclosureSEC source: 0001035267-22-000008 · edgardoc.xml · derivative · entry 9 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,358 Underlying: Common Stock · 270 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 270 | $261.64 | $70,642.80 |
DisclosureSEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 8 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,092 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 270 | $177.99 | $48,056.41 |
DisclosureSEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 7 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 270 | $261.64 | $70,642.80 |
DisclosureSEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,092 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 270 | $179.70 | $48,519.00 |
DisclosureSEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 273 | $261.64 | $71,427.72 |
DisclosureSEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,092 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 273 | $242.34 | $66,157.92 |
DisclosureSEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 597 | $261.64 | $156,199.08 |
DisclosureSEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,092 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 17:00 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 597 | $245.60 | $146,623.20 |
DisclosureSEC source: 0001035267-22-000008 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 21:03 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 273 | $0.00 Strike: $245.60 | $0.00 |
DisclosureSEC source: 0001567619-21-018727 · doc1.xml · derivative · entry 12 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,869 Underlying: Common Stock · 273 shares Expires 2031-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F5 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and 1/48th monthly thereafter, over a four year period of time. F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 21:03 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 198 | $0.00 Strike: $245.60 | $0.00 |
DisclosureSEC source: 0001567619-21-018727 · doc1.xml · derivative · entry 11 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,142 Underlying: Common Stock · 198 shares Expires 2031-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 21:03 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 270 | $0.00 Strike: $242.34 | $0.00 |
DisclosureSEC source: 0001567619-21-018727 · doc1.xml · derivative · entry 10 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,625 Underlying: Common Stock · 270 shares Expires 2030-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48th one month after the date of grant and 1/48th monthly thereafter. F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 21:03 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 273 | $0.00 Strike: $177.99 | $0.00 |
DisclosureSEC source: 0001567619-21-018727 · doc1.xml · derivative · entry 9 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,628 Underlying: Common Stock · 273 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 21:03 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 273 | $339.75 | $92,751.75 |
DisclosureSEC source: 0001567619-21-018727 · doc1.xml · nonDerivative · entry 8 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,092 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 21:03 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 273 | $177.99 | $48,590.37 |
DisclosureSEC source: 0001567619-21-018727 · doc1.xml · nonDerivative · entry 7 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 21:03 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 273 | $339.75 | $92,751.75 |
DisclosureSEC source: 0001567619-21-018727 · doc1.xml · nonDerivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,092 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 21:03 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 273 | $179.70 | $49,058.10 |
DisclosureSEC source: 0001567619-21-018727 · doc1.xml · nonDerivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 21:03 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 270 | $339.75 | $91,732.50 |
DisclosureSEC source: 0001567619-21-018727 · doc1.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,092 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 21:03 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 270 | $242.34 | $65,430.91 |
DisclosureSEC source: 0001567619-21-018727 · doc1.xml · nonDerivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 21:03 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 198 | $339.75 | $67,270.50 |
DisclosureSEC source: 0001567619-21-018727 · doc1.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,092 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 21:03 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 198 | $245.60 | $48,628.80 |
DisclosureSEC source: 0001567619-21-018727 · doc1.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · balance_after: On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 17:13 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,177 | $0.00 Strike: $1,042.25 | $0.00 |
DisclosureSEC source: 0001035267-21-000154 · edgardoc.xml · derivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,177 Underlying: Common Stock · 3,177 shares Expires 2031-08-26 F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 17:13 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 397 | $0.00 Strike: $736.80 | $0.00 |
DisclosureSEC source: 0001035267-21-000154 · edgardoc.xml · derivative · entry 3 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,780 Underlying: Common Stock · 397 shares Expires 2031-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 17:13 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 397 | $1,048.12 | $416,103.64 |
DisclosureSEC source: 0001035267-21-000154 · edgardoc.xml · nonDerivative · entry 2 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 17:13 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 397 | $736.80 | $292,509.60 |
DisclosureSEC source: 0001035267-21-000154 · edgardoc.xml · nonDerivative · entry 1 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 23:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 484 | $0.00 Strike: $727.01 | $0.00 |
DisclosureSEC source: 0001035267-21-000131 · edgardoc.xml · derivative · entry 10 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 965 Underlying: Common Stock · 484 shares Expires 2030-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F5 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 23:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 422 | $0.00 Strike: $539.10 | $0.00 |
DisclosureSEC source: 0001035267-21-000131 · edgardoc.xml · derivative · entry 9 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,026 Underlying: Common Stock · 422 shares Expires 2030-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 23:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 483 | $0.00 Strike: $533.96 | $0.00 |
DisclosureSEC source: 0001035267-21-000131 · edgardoc.xml · derivative · entry 8 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 967 Underlying: Common Stock · 483 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 23:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 2,615 | $967.29 | $2,529,452.89 |
DisclosureSEC source: 0001035267-21-000131 · edgardoc.xml · nonDerivative · entry 7 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 363 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $962.83 to $975.41,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 23:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 483 | $967.23 | $467,172.23 |
DisclosureSEC source: 0001035267-21-000131 · edgardoc.xml · nonDerivative · entry 6 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,978 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $962.83 to $975.41,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 23:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 483 | $533.96 | $257,902.68 |
DisclosureSEC source: 0001035267-21-000131 · edgardoc.xml · nonDerivative · entry 5 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 23:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 422 | $967.23 | $408,171.19 |
DisclosureSEC source: 0001035267-21-000131 · edgardoc.xml · nonDerivative · entry 4 DeSantis Robert · CIK 0001808942 · EVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,978 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $962.83 to $975.41,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.